Loading...
•
Mar 31, 2021
Jaguar Health Q1 2021 Earnings Report
Reported consolidated financial results for the first quarter of 2021, with Mytesi gross sales and net sales increasing.
Key Takeaways
Jaguar Health reported its first quarter 2021 financial results, highlighting a 250% increase in Mytesi gross sales and a 43% increase in net sales.
Mytesi gross sales were approximately $4.6 million, a 250% increase.
Mytesi net sales were approximately $1.2 million, a 43% increase.
The company hosted an investor webcast on May 17, 2021, to discuss the first quarter 2021 financials and business updates.
Jaguar Health is focused on developing novel, plant-based, non-opioid prescription medicines.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...